Trademark: 85480538
Word
TRANSDERMASAL
Status
Registered
Status Code
800
Status Date
Tuesday, April 11, 2023
Serial Number
85480538
Registration Number
4216772
Registration Date
Tuesday, October 2, 2012
Mark Type
5000
Filing Date
Wednesday, November 23, 2011
Published for Opposition
Tuesday, July 17, 2012

Trademark Owner History
Hisamitsu Pharmaceutical Co., Inc. - Original Registrant

Classifications
40 Manufacturing services for others in the field of pharmaceutical products
The mark consists of "TransDermaSal" in stylized letters.
TRANS DERMASAL
Color is not claimed as a feature of the mark.

Trademark Events
Apr 11, 2023
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Apr 11, 2023
Registered And Renewed (First Renewal - 10 Yrs)
Apr 11, 2023
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Apr 11, 2023
Case Assigned To Post Registration Paralegal
Sep 30, 2022
Teas Section 8 & 9 Received
Oct 2, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Apr 30, 2018
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Apr 30, 2018
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 30, 2018
Case Assigned To Post Registration Paralegal
Apr 19, 2018
Teas Section 8 & 15 Received
Oct 2, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 2, 2012
Registered-Principal Register
Jul 17, 2012
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2012
Published For Opposition
Jun 27, 2012
Notification Of Notice Of Publication E-Mailed
Jun 11, 2012
Law Office Publication Review Completed
Jun 5, 2012
Approved For Pub - Principal Register
Jun 4, 2012
Teas/Email Correspondence Entered
Jun 4, 2012
Correspondence Received In Law Office
Jun 1, 2012
Assigned To Lie
May 19, 2012
Teas Response To Suspension Inquiry Received
Mar 8, 2012
Notification Of Letter Of Suspension E-Mailed
Mar 8, 2012
Letter Of Suspension E-Mailed
Mar 8, 2012
Suspension Letter Written
Mar 8, 2012
Assigned To Examiner
Dec 2, 2011
Notice Of Pseudo Mark Mailed
Dec 1, 2011
New Application Office Supplied Data Entered
Nov 26, 2011
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24